Skip to content

A comparison of remifentanil patient-controlled analgesia with epidural analgesia during labor.

A comparison of remifentanil patient-controlled analgesia with epidural analgesia during labor.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27184
Enrollment
20
Registered
2007-11-17
Start date
2007-11-26
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laborpain.

Interventions

1. 10 patients will receive remifentanil patient controlled analgesia
2. 10 patients will receive epidural analgesia
Medication will be started in active labor and will be continued untill full dilation of the cervix is achieved.

Sponsors

Leiden University Medical Centre.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age ? 18 years; 2. Between 37 and 42 weeks of gestation; 3. Singleton pregnancy; 4. ASA physical status I or II.

Exclusion criteria

Exclusion criteria: 1. ASA physical status ? III; 2. Morbid obesity (BMI ? 40 kg/m2); 3. Substance abuse history; 4. High risk patients: including pre-eclampsia (diastolic pressure ? 100 mmHg, proteinuria), severe asthma (daily use of medication), insulin dependent diabetes mellitus, hepatic insufficiency or renal failure; 5. Premature labor; 6. Drug allergy; history of hypersensitivity to opioid or local anesthetic substances; 7. Cervical dilation >5cm.

Design outcomes

Primary

MeasureTime frame
1. Quality of pain relief as determined by Visual Analogue Scale scores; 2. Patient satisfaction; 3. Fetal outcome as determined by Apgar scores, umbilical cord pH, NACS and requirement for naloxone.

Contacts

Public ContactM.R. Douma

Leiden University Medical Center Department of Anesthesiology P.O. Box 9600

maritdouma@hotmail.com0031 (0)6 14276591

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)